Bristol-Myers Squibb Company (BMY) 13D/13G Filings for Compugen Ltd. (CGEN)

Bristol-Myers Squibb Company 13D and 13G filings for Compugen Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
4:10 pm
Sale
2024-12-31 13G Compugen Ltd.
CGEN
BRISTOL MYERS SQUIBB CO
BMY
1,840,136
2.060%
-2,916,922decrease
(-61.32%)
Filing
2021-11-19
4:15 pm
Purchase
2021-11-10 13G Compugen Ltd.
CGEN
BRISTOL MYERS SQUIBB CO
BMY
4,757,058
5.500%
4,757,058increase
(New Position)
Filing